1887

Abstract

We have demonstrated previously that the envelope protein of a murine retrovirus, Moloney murine leukaemia virus, has immunosuppressive properties . This property was manifested by the ability of the protein, when expressed by tumour cells normally rejected by engrafted mice, to allow the -expressing cells to escape immune rejection and to proliferate. Here, it is shown that this property is not restricted to the envelope of a murine retrovirus, but is also shared by the envelope encoded by a primate retrovirus, Mason–Pfizer monkey virus.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-82-7-1597
2001-07-01
2019-09-18
Loading full text...

Full text loading...

/deliver/fulltext/jgv/82/7/0821597a.html?itemId=/content/journal/jgv/10.1099/0022-1317-82-7-1597&mimeType=html&fmt=ahah

References

  1. Arthur, L. O., Gilden, R. V., Marx, P. A. & Gardner, M. B. ( 1986; ). Simian acquired immunodeficiency syndrome. Progress in Allergy 37, 332-352.
    [Google Scholar]
  2. Barker, C. S., Pickel, J., Tainsky, M. & Hunter, E. ( 1986; ). Molecular cloning of the Mason–Pfizer monkey virus genome: biological characterization of genome length clones and molecular comparisons to other retroviruses. Virology 153, 201-214.[CrossRef]
    [Google Scholar]
  3. Brody, B. A. & Hunter, E. ( 1992; ). Mutations within the env gene of Mason–Pfizer monkey virus: effects on protein transport and SU–TM association. Journal of Virology 66, 3466-3475.
    [Google Scholar]
  4. Brody, B. A., Kimball, M. G. & Hunter, E. ( 1994; ). Mutations within the transmembrane glycoprotein of Mason–Pfizer monkey virus: loss of SU–TM association and effects on infectivity. Virology 202, 673-683.[CrossRef]
    [Google Scholar]
  5. Bryant, M. L., Gardner, M. B., Marx, P. A., Maul, D. H., Lerche, N. W., Osborn, K. G., Lowenstine, L. J., Bodgen, A., Arthur, L. O. & Hunter, E. ( 1986; ). Immunodeficiency in rhesus monkeys associated with the original Mason–Pfizer monkey virus. Journal of the National Cancer Institute 77, 957-965.
    [Google Scholar]
  6. Chopra, H. C. & Mason, M. M. ( 1970; ). A new virus in a spontaneous mammary tumor of a rhesus monkey. Cancer Research 30, 2081-2086.
    [Google Scholar]
  7. Cianciolo, G. J., Matthews, T. J., Bolognesi, D. P. & Snyderman, R. ( 1980; ). Macrophage accumulation in mice is inhibited by low molecular weight products from murine leukemia viruses. Journal of Immunology 124, 2900-2905.
    [Google Scholar]
  8. Cianciolo, G. J., Copeland, T. D., Oroszlan, S. & Snyderman, R. ( 1985; ). Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins. Science 230, 453-455.[CrossRef]
    [Google Scholar]
  9. Fine, D. L., Peinta, R. J., Malan, L. B., Kubicek, M. T., Bennett, D. G., Landon, J. C., Valerio, M. G., West, D. M., Fabrizio, D. A. & Chopra, H. C. ( 1974; ). Biologic characteristics of transformed rhesus foreskin cells infected with Mason–Pfizer monkey virus. Journal of the National Cancer Institute 52, 1135-1142.
    [Google Scholar]
  10. Fine, D. L., Landon, J. C., Pienta, R. J., Kubicek, M. T., Valerio, M. G., Loeb, W. F. & Chopra, H. C. ( 1975; ). Responses of infant rhesus monkeys to inoculation with Mason–Pfizer monkey virus materials. Journal of the National Cancer Institute 54, 651-658.
    [Google Scholar]
  11. Haraguchi, S., Good, R. A., Cianciolo, G. J., Engelman, R. W. & Day, N. K. ( 1997; ). Immunosuppressive retroviral peptides: immunopathological implications for immunosuppressive influences of retroviral infections. Journal of Leukocyte Biology 61, 654-666.
    [Google Scholar]
  12. Jensen, E. M., Zelljadt, I., Chopra, H. C. & Mason, M. M. ( 1970; ). Isolation and propagation of a virus from a spontaneous mammary carcinoma of a rhesus monkey. Cancer Research 30, 2388-2393.
    [Google Scholar]
  13. Mangeney, M. & Heidmann, T. ( 1998; ). Tumor cells expressing a retroviral envelope escape immune rejection in vivo. Proceedings of the National Academy of Sciences, USA 95, 14920-14925.[CrossRef]
    [Google Scholar]
  14. Mathes, L. E., Olsen, R. G., Hebebrand, L. C., Hoover, E. A., Schaller, J. P., Adams, P. W. & Nichols, W. S. ( 1979; ). Immunosuppressive properties of a virion polypeptide, a 15,000-dalton protein, from feline leukemia virus. Cancer Research 39, 950-955.
    [Google Scholar]
  15. Monell, C. R. & Strand, M. ( 1994; ). Structural and functional similarities between synthetic HIV gp41 peptides and defensins. Clinical Immunology and Immunopathology 71, 315-324.[CrossRef]
    [Google Scholar]
  16. Naniche, D. ( 2000; ). Generalized immunosuppression: individual viruses, intertwined targets. Virology 275, 227-232.[CrossRef]
    [Google Scholar]
  17. Oostendorp, R. A. J., Meijer, C. J. L. M. & Scheper, R. J. ( 1993; ). Immunosuppression by retroviral-envelope-related proteins, and their role in non-retroviral human disease. Critical Reviews in Oncology/Hematology 14, 189-206.[CrossRef]
    [Google Scholar]
  18. Sonigo, P., Barker, C., Hunter, E. & Wain-Hobson, S. ( 1986; ). Nucleotide sequence of Mason–Pfizer monkey virus: an immunosuppressive D-type retrovirus. Cell 45, 375-385.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-82-7-1597
Loading
/content/journal/jgv/10.1099/0022-1317-82-7-1597
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error